Skyy Luu on Muck Rack

Skyy Luu

As seen in: Journal of Infection
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Skyy

Contact Skyy, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Immunogenicity and efficacy over 12 months following a fourth dose of a bivalent mRNA or protein-based COVID-19 vaccine: A randomised controlled trial in Australia

|
By Nadia Mazarakis, Eleanor Neal, Kathryn Bright, Zheng Quan Toh, Cattram Nguyen, Skyy Luu, Leanne Quah, Yan Yung Ng, John Hart, Anna Rudel, Shashini Dassanayake, Rachel Higgins, Darren Suryawijaya Ong, Fran Justice, Rachael Carissa
| Journal of Infection Verified
Results Between Feb 28 and Oct 4, 2023, a total of 1257 participants were screened for eligibility. Of those, 496 participants were recruited and randomised into either the Moderna (n=177) or Novavax (n=176) vaccine groups or self-selected to a non-randomised control group (n=143) (Fig. 1). Baseline characteristics of study participants in the vaccine groups were reported previously10 and are shown with the control group in Table S1.
Open in Who Shared Issue with article?

The immunogenicity, reactogenicity, and safety of a bivalent mRNA or protein COVID-19 vaccine given as a fourth dose

|
By Paul V. Licciardi, Nadia Mazarakis, Zheng Quan Toh, Kathryn Bright, Yan Yung Ng, Cattram Nguyen, John Hart, Rachel Higgins, Darren Suryawijaya Ong, Kerryn A Moore, Eleanor Neal, Skyy Luu, Leanne Quah, Anna Rudel, Shashini Dassanayake, Fran Justice, Emma Wa
| Journal of Infection Verified
Keywords COVID-19 SARS-CoV-2 vaccination booster antibody immunity Introduction The original COVID-19 vaccines developed at the end of 2020 contained the Spike protein of the SARS-CoV-2 Ancestral strain (WA.1).
Open in Who Shared Issue with article?
See all 2 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified